Core Viewpoint - Xiangyu Medical's stock closed at 45.46 yuan, down 1.60%, with a rolling PE ratio of 83.78 times, indicating a high valuation compared to the industry average [1]. Company Overview - Xiangyu Medical specializes in the research, production, and sales of rehabilitation medical devices, offering over a thousand products across ten categories, including rehabilitation therapy, training, and assessment [2]. - The company has received multiple awards for its projects, including first prizes for various rehabilitation technology initiatives from different medical and scientific associations [2]. Financial Performance - In the first quarter of 2025, the company reported revenue of 186 million yuan, a year-on-year increase of 10.02%, while net profit was 22.95 million yuan, reflecting a decline of 41.26% [3]. - The gross profit margin for the company stood at 65.30% [3]. Industry Comparison - The average PE ratio for the medical device industry is 53.52 times, with a median of 37.14 times, positioning Xiangyu Medical at a significantly higher valuation compared to its peers [1][3]. - The company ranks 102nd in terms of PE ratio within the industry [1].
翔宇医疗收盘下跌1.60%,滚动市盈率83.78倍,总市值72.74亿元